Unconfigured Ad

Collapse

Application of sequencing to RNA analysis (RNA-Seq, whole transcriptome, SAGE, expression analysis, novel organism mining, splice variants)

Forums Topics Posts Last Post
No forums found.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Filter
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Filter
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by jgoecks, 11-29-2010, 02:06 PM
27 responses
75,251 views
0 reactions
Last Post suparmin  
Started by gsca, 08-23-2010, 11:42 PM
0 responses
2,104 views
0 reactions
Last Post gsca
by gsca
 
Started by shazzle, 03-25-2010, 08:23 PM
2 responses
4,337 views
0 reactions
Last Post malachig  
Started by mirauta, 07-06-2010, 12:41 AM
3 responses
10,085 views
0 reactions
Last Post malachig  
Started by jrss, 06-29-2010, 06:33 AM
2 responses
3,255 views
0 reactions
Last Post malachig  
Started by bisrat, 08-23-2010, 08:11 AM
0 responses
3,277 views
0 reactions
Last Post bisrat
by bisrat
 
Started by sc10021, 08-20-2010, 06:15 AM
0 responses
1,691 views
0 reactions
Last Post sc10021
by sc10021
 
Started by jay, 02-26-2010, 02:23 AM
19 responses
11,499 views
0 reactions
Last Post Xi Wang
by Xi Wang
 
Started by [email protected], 07-05-2010, 10:10 PM
3 responses
4,985 views
0 reactions
Last Post konrad98  
Started by kenosaki, 08-08-2010, 11:15 PM
1 response
2,588 views
0 reactions
Last Post townway
by townway
 
Started by kenosaki, 07-09-2010, 03:22 AM
4 responses
3,624 views
0 reactions
Last Post kenosaki  
No topics found.
  • Filter
  • Time
Clear All
widgetinstance 229 (Webinars) skipped due to lack of content & hide_module_if_empty option.

Recent Articles

Collapse

  • mylaser
    Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by mylaser
    Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
    The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
    Whether you're exploring Kheloyaar for the first time or want to understand...
    Today, 09:27 PM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    Today, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    Yesterday, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 10:04 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:08 AM
0 responses
7 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Working...